Page last updated: 2024-10-29

ifosfamide and Acrania

ifosfamide has been researched along with Acrania in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Median age at diagnosis of Ewing sarcoma was 12 years, and median length of follow-up, 8 years."2.73Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. ( Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatia, S1
Krailo, MD1
Chen, Z1
Burden, L1
Askin, FB1
Dickman, PS1
Grier, HE1
Link, MP1
Meyers, PA1
Perlman, EJ1
Rausen, AR1
Robison, LL1
Vietti, TJ1
Miser, JS1

Trials

1 trial available for ifosfamide and Acrania

ArticleYear
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
    Blood, 2007, Jan-01, Volume: 109, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Ch

2007